4//SEC Filing
Lynch Ryan 4
Accession 0001209191-17-053165
CIK 0001367920other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 4:40 PM ET
Size
8.6 KB
Accession
0001209191-17-053165
Insider Transaction Report
Form 4
Lynch Ryan
PFO, PAO
Transactions
- Sale
Common Stock
2017-09-14$14.51/sh−3,500$50,785→ 6,000 total - Exercise/Conversion
Employee Stock Option (right to buy)
2017-09-14−3,500→ 3,200 totalExercise: $9.46Exp: 2024-06-11→ Common Stock (3,500 underlying) - Exercise/Conversion
Common Stock
2017-09-14$9.46/sh+3,500$33,110→ 9,500 total
Footnotes (1)
- [F1]Twenty five percent (25%) of the shares subject to this option vested on June 12, 2015, and the option vested and will continue to vest in equal quarterly installments thereafter, until June 12, 2018, at which time this option will be fully vested.
Documents
Issuer
CONCERT PHARMACEUTICALS, INC.
CIK 0001367920
Entity typeother
Related Parties
1- filerCIK 0001709271
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 4:40 PM ET
- Size
- 8.6 KB